• Business
  • 13 October
  • JP Morgan (JPM) investment banking fees is expected to exceed the stated figure in the Q3
    4
  • Johnson & Johnson (JNJ) Innovation Medicine revenue be above the specified amount in Q3
    2
  • Johnson & Johnson (JNJ) MedTech revenue be above the specified amount in Q3
    8
  • Citigroup (C) provisions for loan losses in the Q3 exceed the stated amount
    6
  • Wells Fargo (WFC) provisions for loan losses in the Q3 exceed the stated amount
    2
  • 14 October
  • Progressive (PGR) combined ratio in Q3
    10
  • Will BlackRock (BLK) quarterly total net inflows be above the specified amount in Q3
    4
  • Will Morgan Stanley's (MS) investment banking revenue be above the specified amount in Q3
    6
  • Will Bank of America (BAC) provisions for loan losses in the Q3 be above the specified amount
    4
  • 15 October
  • Prologis (PLD) core FFO exceed diluted earnings per share in Q3
    2